The role of AhR in tumor growth is confirmed by the slower growth of TDO2-expressing tumors in AhR-deficient mice and the abrogation of clonogenic survival in response to kynurenine in AhR knockdown glioma cells [71]. The gene discussed is AHR; the disease is central nervous system cancer.